Premium
Tumor lysis syndrome following VP‐16‐213 in chronic myeloid leukemia in blast crisis
Author(s) -
Thomas M. Roy,
Robinson W. A.,
Mughal T. I.,
Glode L. Michael
Publication year - 1984
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.2830160211
Subject(s) - tumor lysis syndrome , myeloid leukemia , etoposide , blast crisis , medicine , leukemia , immunology , cytotoxic t cell , chemotherapy , myeloid , cancer research , oncology , biology , biochemistry , in vitro
Several recent reports have emphasized the potentially serious and often fatal acute metabolic complications following cytotoxic chemotherapy in both solid tumors and leukemias. We present here a case of chronic myeloid leukemia in blast crisis who developed an acute tumor lysis syndrome following a single dose of VP‐16‐213 (Etoposide).